Abstract
Gaming Law ReviewVol. 6, No. 2 On the DocketOn the DocketPublished Online:6 Jul 2004https://doi.org/10.1089/10921880252853439AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail "On the Docket." , 6(2), p. 107FiguresReferencesRelatedDetailsCited byCriteria to define rare diseases and orphan drugs: a systematic review protocol29 July 2022 | BMJ Open, Vol. 12, No. 7The Importance of Reference Centers and Registries for Rare Diseases: The Example of Alpha-1 Antitrypsin Deficiency14 August 2020 | COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 17, No. 4, Vol. 1031A model for collaborative clinical research in rare diseases: experience from the Rare Disease Clinical Research Network programClinical Investigation, Vol. 3, No. 11Rare Diseases ResearchChest, Vol. 144, No. 1Perspectives for improving the evaluation and access of therapies for rare lung diseases in EuropeRespiratory Medicine, Vol. 106, No. 6 Volume 6Issue 2Apr 2002 To cite this article:On the Docket.Gaming Law Review.Apr 2002.107-107.http://doi.org/10.1089/10921880252853439Published in Volume: 6 Issue 2: July 6, 2004PDF download
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call